Search
From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Study: Tocilizumab reduces risk for death in patients with severe COVID-19
Treatment with the rheumatoid arthritis drug tocilizumab, sold as Actemra, reduces the risk for death among hospitalized patients with severe COVID-19 by about 30%, a study published by JAMA Internal Medicine found.
New Zealand PM Ardern storms to historic election victory after crushing COVID
New Zealand Prime Minister Jacinda Ardern swept to an historic election victory and said she will use her mandate to rebuild an economy battered by the coronavirus pandemic and tackle social inequality.
Congenital heart defects may not increase the risk of severe COVID-19 symptoms
Adults and children born with heart defects had a lower-than-expected risk of developing moderate or severe COVID-19 symptoms, finds a study of more than 7,000 patients from the congenital heart disease center at Columbia University Vagelos College of Physicians and Surgeons.
Remdesivir has very little effect on COVID-19 mortality, WHO finds
Remdesivir, one of the big treatment hopes for COVID-19, has very little effect on preventing deaths, according to a large and comprehensive trial run by the World Health Organization.
Iran registers 265 new COVID-19 deaths in 24 hours
Iran's Health Ministry announced that the novel coronavirus has killed 265 more Iranians from Thursday to Friday, mounting the total death number to 29,870.
COVID-19 kills 256 more in Iran: Health Ministry
Iran's Health Ministry announced that the novel coronavirus has killed 256 more Iranians from Wednesday to Thursday, mounting the total death number to 29,605.
World Bank approves $12b for COVID-19 vaccines
The World Bank said that it approved $12 billion for developing countries to finance the purchase and distribution of COVID-19 vaccines, tests and treatment.
Study: COVID-19 patients produce 'high-quality' antibodies up to seven months after recovery
People sickened with COVID-19 produce "high-quality" antibodies against the virus five to seven months after they become infected, according to an analysis published by the journal Immunity.
Countries turn to rapid antigen tests to contain second wave of COVID-19
Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those infected quickly.
COVID-19 reinfection casts doubt on virus immunity: Study
COVID-19 patients may experience more severe symptoms the second time they are infected, according to research released Tuesday confirming it is possible to catch the potentially deadly disease more than once.
Pregnant women with COVID-19 don't pass the virus to their newborns, study finds
New mothers infected with COVID-19 during pregnancy didn't pass the virus to their babies, even if they breastfed and shared the same hospital room, according to a study published by JAMA Pediatrics.
Survey shows New Zealand tourism could play vital role in post-COVID economic recovery
A new survey conducted by Wellington-based research and strategy specialists, Angus & Associates, endorses tourism’s potential to create employment and enrich local communities in New Zealand.
White House physician: Trump 'no longer a COVID transmission risk to others'
US President Donald Trump is no longer a COVID transmission risk to others, the White House physician said.
Can a vaccine from 1921 save lives from COVID-19?
Scientists in the UK have begun testing the Bacillus Calmette–Guérin (BCG) vaccine, developed in 1921, to see if it can save lives from COVID-19.
Rental cars weren't cleaned between customers, inside edition's invisible ink test finds
In the age of COVID-19, rental car companies are promising to keep customers safe with enhanced cleaning measures. But using an invisible ink test, Inside Edition's Investigative Unit recently found cars that hadn’t been properly cleaned between customers.

Page Generated in 0/4885 sec